Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis
出版年份 2016 全文链接
标题
Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis
作者
关键词
Nonalcoholic steatohepatitis, Fibrosis, Cirrhosis, Screening
出版物
DIGESTIVE DISEASES AND SCIENCES
Volume 61, Issue 7, Pages 2108-2117
出版商
Springer Nature
发表日期
2016-01-29
DOI
10.1007/s10620-016-4044-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Use of Antidiabetic Drugs in the U.S., 2003–2012
- (2014) Christian Hampp et al. DIABETES CARE
- Review of Utility Values for Economic Modeling in Type 2 Diabetes
- (2014) Amélie Beaudet et al. VALUE IN HEALTH
- Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes
- (2013) Iliana Doycheva et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Patterns of Medication Initiation in Newly Diagnosed Diabetes Mellitus: Quality and Cost Implications
- (2012) Nihar R. Desai et al. AMERICAN JOURNAL OF MEDICINE
- Pioglitazone and vitamin E for nonalcoholic steatohepatitis: A cost utility analysis
- (2012) Suzanne E. Mahady et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States
- (2011) Mark H. Eckman et al. CLINICAL INFECTIOUS DISEASES
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
- (2011) Michael R. Charlton et al. GASTROENTEROLOGY
- The role of thiazolidinediones in non-alcoholic steatohepatitis – A systematic review and meta analysis
- (2011) Suzanne E. Mahady et al. JOURNAL OF HEPATOLOGY
- Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors
- (2011) Nathalie C. Leite et al. LIVER INTERNATIONAL
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
- (2010) Giovanni Musso et al. ANNALS OF MEDICINE
- A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the united states from 2003 to 2005
- (2010) Richard A. Hansen et al. CLINICAL THERAPEUTICS
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
- (2010) Nathalie C. Leite et al. LIVER INTERNATIONAL
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes
- (2009) John Dormandy et al. DRUG SAFETY
- Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
- (2008) Nila Rafiq et al. Clinical Gastroenterology and Hepatology
- Systematic Review: Health-State Utilities in Liver Disease: A Systematic Review
- (2008) David J. McLernon et al. MEDICAL DECISION MAKING
- Long-Term Cost-Effectiveness of Pioglitazone versus Placebo in Addition to Existing Diabetes Treatment: A US Analysis Based on PROactive
- (2008) William J. Valentine et al. VALUE IN HEALTH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More